Page 5 - Sarah Singleton News Today

It must be election year. Our governor wants to give teachers an across-the-board 7 percent raise next year. Gov. Michelle Lujan Grisham is keeping the New Mexico tradition of spending

It must be election year. Our governor wants to give teachers an across-the-board 7 percent raise next year. Gov. Michelle Lujan Grisham is keeping the New Mexico tradition of spending

Lung-MAP trials are studying how well investigational or new drugs work in non-small cell lung cancer (NSCLC) patients and will study how N-803 (Anktiva) could bolster the current standard of care, checkpoint inhibitors.ImmunityBio’s study will test its IL-15 receptor superagonist complex N-803 (Anktiva) in combinat...

.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... Legislative Education Study Committee (LESC) director Rachel Gudgel has got to go. Her very presence in government is precisely the representation of systemic racism we must eliminate and hold accountable. In 2018, our Legislature was tasked with taking immediate action to overhaul the state’s educ...

Judge Orders New Mexico to Expedite Delivery of School Tech After a lawsuit alleged the state of New Mexico failed to provide necessary devices and connectivity for students to participate in remote learning, a judge has ordered the state to assess the cost and get it done. May 19, 2021 •  David Kidd/Governing (TNS) — Less than three weeks ago, a judge ordered New Mexico to provide computers and high-speed Internet to at-risk students for remote learnin...

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection The first COVID-19 vaccine trials designed to deliver both S and N SARS-CoV-2 viral proteins via multiple routes—subcutaneous, sublingual, and oral Oral capsule stimulates immunity to both S and N proteins and could potentially serve as a universal boost to other S-based (antibody-based) vaccines and reduce transmission T-cell vaccine could potentially address escape m...

Search jobs NantKwest, ImmunityBio Announce Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Trials Pivotal QUILT 88 trial based on combination immunotherapy of “Cancer Moonshot” strategy; early indications of increased survival rate for pancreatic cancer patients with no other approved treatment options In initial Cancer Moonshot QUILT trials of haNK and avelumab (PD-L1 checkpoint inhibitor) completed in 2019, median overall survival rate mor...

Press release content from Business Wire. The AP news staff was not involved in its creation. NantKwest, ImmunityBio Announce Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Trials January 13, 2021 GMT EL SEGUNDO & CULVER CITY, Calif.--(BUSINESS WIRE)--Jan 13, 2021-- NantKwest, Inc. ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, and ImmunityBio, Inc., a privately-held immunotherapy company, today announced early interim results of its P...